title: Failed Alzheimer's trial does not kill leading theory of disease.
authors.forename: Alison
authors.initials: A
authors.lastname: Abbott
authors.forename: Elie
authors.initials: E
authors.lastname: Dolgin
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control; D000682:Amyloid / Q000096:biosynthesis / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004198:Disease Susceptibility; D004345:Drug Industry / Q000191:economics; D006801:Humans; D008954:Models, Biological; D058990:Molecular Targeted Therapy; D015203:Reproducibility of Results; D035501:Uncertainty
chemical_list: D000682:Amyloid; D061067:Antibodies, Monoclonal, Humanized; C000600266:aducanumab; C550616:solanezumab